The diabetes pill Avandia may cause significant heart risks. The FDA is now investigating and news is pouring out about the drug.
Avandia, sold by the British company GlaxoSmithKline PLC, is a blockbuster medication used to treat Type...
[more]
The diabetes pill Avandia may cause significant heart risks. The FDA is now investigating and news is pouring out about the drug.
Avandia, sold by the British company GlaxoSmithKline PLC, is a blockbuster medication used to treat Type 2 diabetes, the most common form of the disease. More than 6 million people worldwide have taken the drug, whose U.S. sales topped $2.2 billion last year.
Date Published: Friday, December 11th, 2009
A federal judge overseeing the Avandia multidistrict litigation has ordered GlaxoSmithKline to produce dozens of documents in a lawsuit over Avandia’s heart side effects. In doing so, the judge rejected Glaxo’s claim that the documents were subject to attorney-client or work product privilege.
Avandia’s cardiovascular problems have been the subject of concern since May 2007, when an analysis of 42 clinical trails published by the... Read Full Story
Date Published: Thursday, October 15th, 2009
The diabetes drug Avandia has been linked to so many health problems that some have questioned whether or not it should be on the market at all.
In November 2007, a warning detailing Avandia’s association with myocardial ischemia was added to the drug’s boxed warning. The warning followed an analysis of 42 clinical trails published by the Cleveland Clinic in May 2007 that found patients taking Avandia had a 43-percent higher risk... Read Full Story
WASHINGTON he controversy surrounding GlaxoSmithKline's diabetes drug Avandia grew Wednesday as a medical expert told Congress that executives threatened to sue when he first raised questions in 1999 about the treatment's safety.That testimony, coupled with a recent medical journal analysis highlighting the heart attack risks associated with Avandia, prompted some Democratic lawmakers to rebuke the Food and Drug Administration for failing to protect consumers, and to call for stricter... Read Full Story
Date Published: Monday, September 28th, 2009
Another study involving Avandia has found an increased risk of heart failure among patients taking the controversial diabetes drug. The Canadian study was published this month in the British Medical Journal.
Avandia’s cardiovascular side effects first became the subject of concern in May 2007, when an analysis of 42 clinical trails published by the Cleveland Clinic showed that patients taking the drug had a 43-percent higher risk... Read Full Story
Many of us suffer from type 2 diabetes. In fact there are about 14 million people in the United States who are in this situation and a good number are being treated with Avandia, a medicine designed to increase the body’s sensitivity to insulin. The drug was first marketed in 1999 by GlaxoSmithKline and it became so popular among physicians that more than 60 million prescriptions have been written. Avandia, also know as rosiglitazone, is an oral anti-diabetic agent that also improves... Read Full Story
Date Published: Wednesday, August 19th, 2009
The diabetes drug Avandia carries more risk than Actos, a new study conducted by Canadian researchers has found. According to a Reuters report, seniors in the study taking Avandia were more likely to suffer from heart failure, and were more likely to die. The findings prompted the authors of the study to question the continuing use of Avandia.
According to Reuters, researchers at Sunnybrook Health Sciences Centre in Toronto... Read Full Story
The U.S. Food and Drug Administration announced that the drug Avandia will now carry a “black box” warning (the most serious a drug can carry) saying that there may be an increased risk of heart attack associated with its use.
GlaxoSmithKline’s Avandia is used by millions of Americans with type 2 diabetes and until this summer was the top-selling diabetes pill in the world.
(more…)
Share This
Read Full Story
Date Published: Wednesday, July 29th, 2009
According to emerging research, GlaxoSmithKline’s diabetes drug, Avandia , can cause death as a result of liver failure, and should be banned by the U.S. Food & Drug Administration (FDA). The group, Public Citizen, published the research in the peer-reviewed medical journal Pharmacoepidemiology and Drug Safety.
According to Public Citizen , it petitioned the FDA to ban Avandia as far back as October due to its risks, including... Read Full Story
But study found diabetes drug didn't increase chances of heart disease, death
Share
What is this?
Buzz
Digg
Facebook
More...
EMAIL
PRINT
RSS
FRIDAY, June 5 (HealthDay News) -- The diabetes drug Avandia significantly raises the risk of both heart failure and bone fractures, but it does not boost the odds for either cardiovascular disease or death, new research has found.
If anything, the drug may slightly lower the... Read Full Story
Posted by
god
31 minutes ago
( http://www.boston.com )
View profile
Category : Business
MINNEAPOLIS - GlaxoSmithKline PLC's diabetes drug Avandia, linked to heart attacks in a study last year, failed to slow the progression of heart disease better than an older medicine, a company funded study found.
Read Full Story
